Consequently, we concluded that the downregulation of miR-301 could restrain the tumor growth in ESCC through the high expression of PTEN, and the similar conclusion has also been unveiled in breast cancer [10] and prostate cancer [28]. Here, PTEN is linked to prostate carcinoma.